UTI EBITDA Guidance Cut Investigation
Analysis based on 7 articles · First reported Aug 10, 2026 · Last updated Aug 17, 2026
The guidance cut and subsequent investigation have negatively impacted UTI's stock price, reflecting investor concerns about the company's profitability and disclosure practices. The investigation could lead to legal costs and potential settlements, further affecting UTI's financial position and market sentiment.
Universal Technical Institute (UTI) lowered its fiscal 2026 baseline adjusted EBITDA outlook to above $135 million from more than $155 million, a reduction of roughly $20 million, citing weaker-than-expected fourth-quarter starts in the high-school auto and diesel channel and a faster mix shift toward shorter-duration, lower-margin programs. The company reported fiscal Q3 2026 revenue of $218.9 million, up 7.2% year over year, but shares fell sharply from $42.37 to $27.87, a decline of nearly 35%. Levi & Korsinsky, LLP launched an investigation into potential securities law violations, focusing on whether UTI adequately disclosed the risks to its outlook before the reduction. The investigation references statements made on the May 6, 2026 earnings call by CFO Bruce Schuman and CEO Jerome Grant, who reaffirmed the outlook and expressed confidence in student starts. The firm is seeking investors who suffered losses to participate in the investigation.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard